‘The Doors are Wide Open’: Denver Cannabis Company Gets DEA Approval To Expand Alzheimer’s Research
Cannabis Law Report
JULY 23, 2021
We’re interested in how cannabinoids affect the nervous system, the brain, and in in particular, we’re very interested in Alzheimer’s disease,” said Dr. Tyrell Towle, director of chemistry and extraction at MedPharm. According to Towle, MedPharm’s researchers hope to find whether cannabinoids can treat symptoms or even prevent the disease.
Let's personalize your content